Protocols for investigating microRNA functions in human neural progenitor cells. 2012

Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.

Human embryonic stem cells and induced pluripotent stem cells offer great hope for studies of pathogenic mechanisms of disease and cell-based therapies. One powerful approach to manipulate the behaviors of human stem cells and their progenies is through microRNAs (miRNAs), a class of small noncoding RNAs that regulate gene expression at the posttranscriptional level. Each miRNA may target up to hundreds of mRNAs; some are specifically expressed in progenitor cells and affect multiple cellular processes. Here we present experimental protocols for investigating the endogenous functions of specific miRNAs in the proliferation, survival, and migration of human neural progenitor cells derived from embryonic stem cells. These methods may be applicable to protein factors and neural progenitor cells derived from patient-specific induced pluripotent stem cells.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
August 2010, Cell cycle (Georgetown, Tex.),
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
May 2013, Journal of leukocyte biology,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
April 2010, Cell stem cell,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
January 2022, Methods in molecular biology (Clifton, N.J.),
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
November 2012, Nature neuroscience,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
September 2015, Development (Cambridge, England),
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
August 2009, Nature,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
March 2009, Expert opinion on therapeutic patents,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
February 2004, Neuroreport,
Sandra Almeida, and Celine Delaloy, and Lei Liu, and Fen-Biao Gao
August 2020, Molecular medicine reports,
Copied contents to your clipboard!